Cargando…
Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients
Patients with late stage resected cutaneous melanoma have poor overall survival (OS) and experience irreversible adverse events from systemic therapy. There is a clinical need to identify biomarkers to predict outcome. Performing germline/tumour whole-exome sequencing of 44 stage III/IV melanoma pat...
Autores principales: | Aoude, Lauren G., Bonazzi, Vanessa F., Brosda, Sandra, Patel, Kalpana, Koufariotis, Lambros T., Oey, Harald, Nones, Katia, Wood, Scott, Pearson, John V., Lonie, James M., Arneil, Melissa, Atkinson, Victoria, Smithers, B. Mark, Waddell, Nicola, Barbour, Andrew P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572377/ https://www.ncbi.nlm.nih.gov/pubmed/33077847 http://dx.doi.org/10.1038/s41598-020-74956-3 |
Ejemplares similares
-
ctDNA as a biomarker of progression in oesophageal adenocarcinoma
por: Bonazzi, V.F., et al.
Publicado: (2022) -
The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy – results from the AGITG DOCTOR trial and the cancer evolution biobank
por: Lonie, James M., et al.
Publicado: (2023) -
Complex structural rearrangements are present in high-grade dysplastic Barrett’s oesophagus samples
por: Newell, Felicity, et al.
Publicado: (2019) -
Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy
por: M. Naeini, Marjan, et al.
Publicado: (2023) -
Verifying explainability of a deep learning tissue classifier trained on RNA-seq data
por: Yap, Melvyn, et al.
Publicado: (2021)